Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Published August 16, 2017 · Recall initiated: July 26, 2017
Summary
FDA records drug Class II recall D-1080-2017, published August 16, 2017 and initiated July 26, 2017. Recalling firm: HOSPIRA INC, LAKE FOREST; Status: Terminated; Reported quantity: 14,300 vials; Lot: Lot #: 560053F, Exp. 01AUG2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Silicone oil
What to do
Voluntary: Firm initiated · Telephone
Get an email if HYDROMORPHONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer
- HOSPIRA INC, LAKE FOREST
- Distributor
- Nationwide in the USA
- UPC
- 0307030110038
- Lot
- Lot #: 560053F, Exp. 01AUG2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High PotencyMarch 21, 2018
- FDAHYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only,September 27, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100August 16, 2017
- FDAHydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per cartonAugust 16, 2017
- FDARocuronium Bromide Injection Solution 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Syringe, Rx Only, Cantrell DrugAugust 16, 2017
- FDANeostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, CantrellAugust 16, 2017
Questions about this recall
Was Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01 recalled?
Yes. FDA published recall D-1080-2017 on August 16, 2017. Reported hazard: Presence of Particulate Matter: Silicone oil
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROMORPHONE HYDROCHLORIDE. UPC: 0307030110038.